Month: May 2024

– Additional Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Anticipated in the Second Half of 2024 – WALTHAM, Mass., May 02, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today reported financial results for the first quarter of 2024 and recent business highlights. “I am excited about the opportunity that Dyne, its FORCE™ platform and pipeline present for individuals living with serious muscle diseases,” said John Cox, president and chief executive officer of Dyne. “The initial datasets announced in January from our DM1 and DMD programs were promising, and we look forward to reporting additional data...

WINTER PARK, Fla., May 02, 2024 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced its operating results and earnings for the quarter ended March 31, 2024. First Quarter and Recent HighlightsReported Net Income per diluted share attributable to common stockholders of $0.20 for the quarter ended March 31, 2024. Reported Core FFO per diluted share attributable to common stockholders of $0.48 for the quarter ended March 31, 2024. Reported AFFO per diluted share attributable to common stockholders of $0.52 for the quarter ended March 31, 2024. Invested $71.0 million into two retail property acquisitions, totaling 319,066 leasable square feet at a weighted-average going-in cash cap rate of 8.0%.  Sold one property for $20.0 million at an exit cap rate of 8.2%, generating a gain of $4.6...

Company Reaffirms Expectation to Deliver Double-Digit Revenue and ARR Growth in 2024 Cost Optimization Initiatives Drive $0.6 Million Reduction in Operating Loss to $1.0 Million in Q1 2024 BURLINGTON, Mass., May 02, 2024 (GLOBE NEWSWIRE) — Aware, Inc. (NASDAQ: AWRE), a global biometric platform company that uses data science, machine learning, and artificial intelligence to tackle everyday business and identity challenges through biometric solutions, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 and Recent Operational HighlightsTotal revenue increased 3% year-over-year to $4.4 million. Recurring revenue increased 3% year-over-year to $3.1 million (or 71% of total revenue), underscoring the Company’s continued drive to secure and expand its recurring revenue base. Operating expenses...

Q1 GAAP EPS of $1.05; Adjusted EPS* of $1.25    Strong Demand and Execution in HVAC Raising 2024 Full-Year Adjusted EPS* Guidance to a Range of $5.15 to $5.40 CHARLOTTE, N.C., May 02, 2024 (GLOBE NEWSWIRE) — SPX Technologies, Inc. (NYSE:SPXC) (“SPX”, the “Company”, “we” or “our”) today reported results for the first quarter ended March 30, 2024. Gene Lowe, President and CEO, remarked, “I’m very pleased with our strong Q1 performance, which included substantial growth in all of our key profit measures and significant margin expansion in both segments. During the quarter we continued to see solid demand across several key markets and our businesses executed well operationally.” Mr. Lowe continued, “During Q1, we made significant progress on several key value creation initiatives, including driving greater efficiencies in our production...

Delivers Steady Revenue, Adjusted EBITDA and Profit Growth in Q1 2024 TORONTO, May 02, 2024 (GLOBE NEWSWIRE) — Altus Group Limited (ʺAltus” or “the Company”) (TSX: AIF), a leading provider of asset and fund intelligence for commercial real estate (“CRE”), announced today its financial and operating results for the first quarter ended March 31, 2024 and the approval by its Board of Directors (“Board”) of the payment of a cash dividend of $0.15 per common share for the second quarter ending June 30, 2024.   Unless otherwise indicated, all amounts are in Canadian dollars and percentages are on an as reported basis in comparison to Q1 2023. Q1 2024 SummaryConsolidated revenues were $199.5 million, up 4.6% (4.3% on a Constant Currency* basis). Profit (loss) was $(0.2) million, compared to $(2.4) million.   Earnings per share (“EPS”)...

Approximately $750 million in cash, cash equivalents and investments at end of Q1 2024, expected to fund operations into second half of 2026 CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today reported first quarter 2024 financial results and corporate highlights. “We have started 2024 with a focus on maintaining strong execution across our portfolio,” said Sanjiv Patel, M.D., President and Chief Executive Officer of Relay Therapeutics. “We continue to progress a robust RLY-2608 development program and expect to share additional data in the second half of the year. In parallel, we have continued to advance our pre-clinical pipeline...

First Quarter 2024 HighlightsTotal revenue of $1.35 billion, up 7% year over year Service revenue of $944 million, up 24% year over year GAAP operating margin of 23.7% Non-GAAP operating margin of 28.5%1 Cash flow from operations of $830 million Free cash flow of $609 million1SUNNYVALE, Calif., May 02, 2024 (GLOBE NEWSWIRE) — Fortinet® (Nasdaq: FTNT), a global cybersecurity leader driving the convergence of networking and security, today announced financial results for the first quarter ended March 31, 2024. “We are diligently executing on our strategy announced six months ago to leverage our scale, go-to-market capabilities, customer-first focus, and engineering expertise to capitalize on the fast-growing Unified SASE and Security Operations markets while continuing to gain market share in Secure Networking,” said Ken Xie,...

NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) — AdTheorent Holding Company, Inc. (Nasdaq: ADTH) (“AdTheorent” or “the Company”), a machine learning pioneer and industry leader using privacy-forward solutions to deliver measurable value for programmatic advertisers, today announced its first quarter 2024 financial results. First Quarter 2024 Financial Overview:Revenue was $34.9 million, a 6.7% increase compared to $32.7 million in the first quarter of 2023. Gross profit was $14.3 million, down 0.2%, from the first quarter of 2023. Gross Profit Margin was 40.9%, compared to 43.7% in the first quarter of 2023. Adjusted Gross Profit* increased $1.5 million, or 7.1%, to $22.4 million compared to the first quarter of 2023. Adjusted Gross Profit Margin was 64.2% compared to 64.0% in the first quarter of 2023. Net loss was $9.9 million compared...

BURLINGTON, Mass., May 02, 2024 (GLOBE NEWSWIRE) — LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2024 results, announced a $0.16/share quarterly dividend and provided guidance. Q1 2024 Financial ResultsSales $53.5mm, +14% (+11% organic) vs. Q1 2023   Gross margin 68.6%, +300 bps Op. income $11.9mm, +51% Op. margin 22% Net income $9.9mm, +64% Earnings per diluted share $0.44, +62% Cash up $3.2mm sequentially to $108.3mmAllografts (+31%), bovine patches (+13%), carotid shunts (+27%) and distributed porcine patches drove Q1 sales. APAC sales increased 44%, EMEA 17% and the Americas 10%. The gross margin increased to 68.6% in Q1 (vs. 65.6% in Q1 2023) driven by average selling price increases and manufacturing efficiencies offset by product mix. Operating income of $11.9mm was...